Get the Stockscreener App
32.12
6.17%
1.95
Tyra Biosciences Inc stock is traded at $32.12, with a volume of 313.95K.
It is up +6.17% in the last 24 hours and up +23.38% over the past month.
Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.
See More
Previous Close:
$30.17
Open:
$30.27
24h Volume:
313.95K
Relative Volume:
0.60
Market Cap:
$1.71B
Revenue:
-
Net Income/Loss:
$-83.74M
P/E Ratio:
-19.95
EPS:
-1.61
Net Cash Flow:
$-64.98M
1W Performance:
+8.54%
1M Performance:
+23.38%
6M Performance:
+189.60%
1Y Performance:
+106.65%
1-Day Range:
$29.72
$32.15
1-Week Range:
$28.51
$32.09
52-Week Range:
$6.42
$32.09
Tyra Biosciences Inc Stock (TYRA) Company Profile
Name
Tyra Biosciences Inc
Sector
Industry
Phone
(619) 728-4760
Address
2656 STATE STREET, CARLSBAD
Compare TYRA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TYRA
Tyra Biosciences Inc
|
32.12 | 1.61B | 0 | -83.74M | -64.98M | -1.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.46 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
768.11 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
865.87 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
358.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
335.40 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Tyra Biosciences Inc Stock (TYRA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-03-25 | Initiated | Raymond James | Strong Buy |
| May-21-25 | Resumed | Piper Sandler | Overweight |
| Jan-07-25 | Initiated | UBS | Buy |
| Oct-18-24 | Upgrade | BofA Securities | Neutral → Buy |
| Aug-15-24 | Initiated | Piper Sandler | Overweight |
| Dec-15-23 | Downgrade | BofA Securities | Buy → Neutral |
| Jun-30-23 | Initiated | Wedbush | Outperform |
| Feb-03-23 | Initiated | Oppenheimer | Outperform |
| Jun-23-22 | Initiated | H.C. Wainwright | Buy |
| Mar-08-22 | Upgrade | Jefferies | Hold → Buy |
| Nov-08-21 | Downgrade | Jefferies | Buy → Hold |
| Oct-11-21 | Initiated | BofA Securities | Buy |
| Oct-11-21 | Initiated | Cowen | Outperform |
| Oct-11-21 | Initiated | Jefferies | Buy |
View All
Tyra Biosciences Inc Stock (TYRA) Latest News
Technical Analysis: Can Tyra Biosciences Inc continue delivering strong returns2025 Buyback Activity & Safe Investment Capital Preservation Plans - baoquankhu1.vn
(TYRA) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Tyra Biosciences (NASDAQ:TYRA) Stock Rating Lowered by Wall Street Zen - MarketBeat
Tyra Biosciences (NASDAQ:TYRA) Shares Down 5.1%What's Next? - MarketBeat
Piper Sandler Issues Positive Forecast for Tyra Biosciences (NASDAQ:TYRA) Stock Price - MarketBeat
Piper Sandler raises Tyra Biosciences stock price target to $42 on growth outlook - Investing.com Canada
Tyra Biosciences stock hits 52-week high at 30.85 USD By Investing.com - Investing.com Australia
Tyra Biosciences (NASDAQ:TYRA) Sets New 1-Year HighHere's Why - MarketBeat
Tyra Biosciences stock hits 52-week high at 30.85 USD - Investing.com
Tyra Biosciences, Inc. (NASDAQ:TYRA) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Tyra Biosciences, Inc. (NASDAQ:TYRA) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Non-Muscle Invasive Bladder Cancer Pipeline and Clinical Trial - openPR.com
Tyra Biosciences (TYRA) Is Up 9.4% After New COO Hire And 52-Week High Has The Bull Case Changed? - Sahm
Can Tyra Biosciences Inc. stock surprise with earnings upsideJuly 2025 Drop Watch & Technical Entry and Exit Alerts - ulpravda.ru
About Us | Cabling Installation & MaintenanceTyra Biosciences, Inc.Common Stock (Nasdaq:TYRA) Price Chart - FinancialContent
Tyra Biosciences, Inc. (TYRA) Stock Analysis: A Biotech With A Potential 10.61% Upside - DirectorsTalk Interviews
Is Tyra Biosciences Inc. stock a dividend growth opportunity2025 Key Lessons & Weekly High Return Forecasts - Улправда
Tyra Biosciences stock hits 52-week high at $30.27 By Investing.com - Investing.com India
Tyra Biosciences stock hits 52-week high at $30.27 - Investing.com
How Tyra Biosciences Inc. stock reacts to global recession fearsPortfolio Risk Summary & AI Driven Stock Reports - Улправда
Tyra Biosciences (NASDAQ:TYRA) Hits New 12-Month HighHere's Why - MarketBeat
BofA Securities Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Raises Target Price to $32 - 富途牛牛
Promising Growth Stocks To Follow Now – January 5th - Defense World
Tyra Biosciences (NASDAQ:TYRA) Shares Down 6%What's Next? - MarketBeat
Is Tyra Biosciences Inc a good long term investmentInsider Selling Patterns & Fast Growing Investment Ideas - earlytimes.in
Tyra Biosciences (NASDAQ:TYRA) Rating Increased to Hold at Wall Street Zen - Defense World
(TYRA) Movement as an Input in Quant Signal Sets - Stock Traders Daily
June Brings on Some Huge Insider Buying - AOL.com
Tyra Biosciences, Inc. (TYRA) Stock Analysis: Exploring a 25% Upside Potential in the Biotech Space - DirectorsTalk Interviews
Tyra Biosciences (NASDAQ:TYRA) Reaches New 1-Year High – Still a Buy? - Defense World
Tyra Biosciences stock hits 52-week high at $26.36 By Investing.com - Investing.com Nigeria
Tyra Biosciences (NASDAQ:TYRA) Reaches New 1-Year HighTime to Buy? - MarketBeat
Tyra Biosciences stock hits 52-week high at $26.36 - Investing.com
Wedbush Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Raises Target Price to $37 - 富途牛牛
Is Tyra Biosciences Inc. stock gaining market shareMACD Histogram Signals & Start Learning With Our Courses - bollywoodhelpline.com
Tyra Biosciences (NASDAQ:TYRA) Cut to Sell at Wall Street Zen - MarketBeat
Tyra Biosciences Reports Increased Loss Amid R&D Investments - MSN
Tyra Biosciences (NASDAQ:TYRA) Reaches New 52-Week HighHere's What Happened - MarketBeat
Does Tyra Biosciences (TYRA) Index Inclusion Mark a Turning Point in Its Institutional Story? - Yahoo Finance
Tyra Biosciences Director Sells 247,000 Shares for $5 Million After 38% Rally - Yahoo Finance
(TYRA) Volatility Zones as Tactical Triggers - Stock Traders Daily
Tyra Biosciences, Inc. (NASDAQ:TYRA) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Tyra Biosciences director more sells $250k in shares By Investing.com - Investing.com South Africa
Tyra Biosciences director more sells $250k in shares - Investing.com
Tyra Biosciences, Inc.(NasdaqGS: TYRA) added to S&P Biotechnology Select Industry Index - marketscreener.com
Will Tyra Biosciences Inc. stock remain a Wall Street favorite2025 Winners & Losers & AI Powered Trade Plan Recommendations - Улправда
Tyra Biosciences (TYRA) Is Up 12.7% After Wedbush Highlights Pipeline Momentum And Leadership RefreshWhat's Changed - Sahm
Tyra Biosciences (NASDAQ:TYRA) Director Sells $250,000.00 in Stock - MarketBeat
Chmn More Sells 10,000 ($250K) Of Tyra Biosciences Inc [TYRA] - TradingView — Track All Markets
Tyra Biosciences stock hits 52-week high at 24.05 USD By Investing.com - Investing.com Nigeria
Tyra Biosciences Inc Stock (TYRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.05%
0.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):